Virtu KCG Holdings’s ProShares Ultra Health Care RXL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-22,552
Closed -$396K 3411
2017
Q1
$396K Sell
22,552
-6,528
-22% -$110K 0.01% 1619
2016
Q4
$437K Buy
+29,080
New +$441K 0.01% 1655
2016
Q3
Sell
-40,968
Closed -$655K 3417
2016
Q2
$655K Sell
40,968
-31,116
-43% -$481K 0.01% 1108
2016
Q1
$1.03M Sell
72,084
-29,640
-29% -$413K 0.03% 582
2015
Q4
$1.68M Buy
101,724
+67,800
+200% +$1.09M 0.03% 498
2015
Q3
$483K Buy
+33,924
New +$604K 0.01% 1565
2015
Q1
Sell
-15,288
Closed -$237K 3766
2014
Q4
$237K Buy
+15,288
New +$225K ﹤0.01% 2665
2014
Q2
Sell
-43,768
Closed -$494K 4003
2014
Q1
$494K Buy
43,768
+23,000
+111% +$254K 0.01% 1976
2013
Q4
$211K Buy
+20,768
New +$196K ﹤0.01% 3075

Other funds holding RXL

Virtu KCG Holdings's RXL Position: Q2 2017 in Review

Virtu KCG Holdings sold out of ProShares Ultra Health Care (RXL) in Q2 2017, closing a stake of 22,552 shares — an estimated $396K sold.

Virtu KCG Holdings first reported a position in RXL in Q4 2013 and held it in 9 quarters. The position peaked at $1.68M in Q4 2015. 16 funds tracked by Wall St. Rank hold RXL as of Q2 2017.

  • Virtu KCG Holdings reported no remaining ProShares Ultra Health Care position as of Q2 2017 after selling out during the quarter.
  • Virtu KCG Holdings sold 22,552 ProShares Ultra Health Care shares in Q2 2017, an estimated $396K.
  • Virtu KCG Holdings first reported a position in ProShares Ultra Health Care in Q4 2013 and held it in 9 quarters.
  • Virtu KCG Holdings's ProShares Ultra Health Care position peaked at $1.68M in Q4 2015.
  • 16 funds tracked by Wall St. Rank held ProShares Ultra Health Care as of Q2 2017.

Based on Virtu KCG Holdings's 13F filing for Q2 2017, filed 11 Aug 2017.